These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 14717931

  • 1. The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome.
    Kronenberg F, Lingenhel A, Lhotta K, Rantner B, Kronenberg MF, König P, Thiery J, Koch M, von Eckardstein A, Dieplinger H.
    Kidney Int; 2004 Feb; 65(2):606-12. PubMed ID: 14717931
    [Abstract] [Full Text] [Related]

  • 2. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C, Rader D, Bartens W, Krämer J, Brewer HB, Schollmeyer P, Wieland H.
    Ann Intern Med; 1993 Aug 15; 119(4):263-9. PubMed ID: 8328733
    [Abstract] [Full Text] [Related]

  • 3. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.
    Milionis HJ, Efstathiadou Z, Tselepis AD, Bairaktari ET, Tsironis LD, Tsatsoulis A, Elisaf MS.
    Thyroid; 2003 Apr 15; 13(4):365-9. PubMed ID: 12804105
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C, Bartens W, Nauck M, Zäuner I, Greiber S, Schollmeyer P.
    Miner Electrolyte Metab; 1996 Apr 15; 22(1-3):26-30. PubMed ID: 8676820
    [Abstract] [Full Text] [Related]

  • 5. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.
    Kronenberg F, Kuen E, Ritz E, Junker R, König P, Kraatz G, Lhotta K, Mann JFE, Müller GA, Neyer U, Riegel W, Riegler P, Schwenger V, VON Eckardstein A.
    J Am Soc Nephrol; 2000 Jan 15; 11(1):105-115. PubMed ID: 10616846
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dyslipidemia and nephrotic syndrome: recent advances.
    Kronenberg F.
    J Ren Nutr; 2005 Apr 15; 15(2):195-203. PubMed ID: 15827892
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Decrease of Lp(a) during weight reduction in obese children is modified by the apo(a) kringle-IV copy number variation.
    Brandstätter A, Lingenhel A, Zwiauer K, Strobl W, Kronenberg F.
    Int J Obes (Lond); 2009 Oct 15; 33(10):1136-42. PubMed ID: 19636317
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
    Sechi LA, Zingaro L, Catena C, Perin A, De Marchi S, Bartoli E.
    Kidney Int; 1999 Sep 15; 56(3):1049-57. PubMed ID: 10469373
    [Abstract] [Full Text] [Related]

  • 11. Pentanucleotide repeat and size polymorphisms in the apolipoprotein(a) gene are associated with the lipoprotein(a) concentration in chronic hemodialysis patients.
    Tanaka M, Yanagi H, Ando R, Kurihara S, Hirano C, Kobayashi K, Kikuchi S, Hamaguchi H, Tsuchiya S, Tomura S.
    Nephron; 1999 Sep 15; 81(4):414-20. PubMed ID: 10095177
    [Abstract] [Full Text] [Related]

  • 12. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
    Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, Graf H, König P.
    J Clin Invest; 1993 Feb 15; 91(2):397-401. PubMed ID: 8432847
    [Abstract] [Full Text] [Related]

  • 13. Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.
    Brown CD, Azrolan N, Thomas L, Roberts KG, Bostom A, Zhao ZH, Friedman EA.
    Am J Kidney Dis; 1995 Jul 15; 26(1):170-7. PubMed ID: 7611249
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension.
    Sechi LA, Kronenberg F, De Carli S, Falleti E, Zingaro L, Catena C, Utermann G, Bartoli E.
    JAMA; 1997 Jun 04; 277(21):1689-95. PubMed ID: 9169895
    [Abstract] [Full Text] [Related]

  • 16. [Study of lipoprotein (a) phenotypes in Ivorian subject].
    Tiahou G, Aveynier E, Djessou P, Sess D, Cristol JP.
    Bull Soc Pathol Exot; 2005 Jun 04; 98(2):99-103. PubMed ID: 16050374
    [Abstract] [Full Text] [Related]

  • 17. Lipoprotein(a) in the nephrotic syndrome: molecular analysis of lipoprotein(a) and apolipoprotein(a) fragments in plasma and urine.
    Doucet C, Mooser V, Gonbert S, Raymond F, Chapman J, Jacobs C, Thillet J.
    J Am Soc Nephrol; 2000 Mar 04; 11(3):507-513. PubMed ID: 10703674
    [Abstract] [Full Text] [Related]

  • 18. Apo(a) phenotypes and lp(a) concentrations in renal transplant patients.
    Kandoussi AM, Hugue V, Cachera C, Hazzan M, Dracon M, Tacquet A, Noël C.
    Nephron; 1998 Oct 04; 80(2):183-7. PubMed ID: 9736817
    [Abstract] [Full Text] [Related]

  • 19. Apo(a) isoforms do not predict risk for coronary heart disease in a Gulf Arab population.
    Akanji AO.
    Ann Clin Biochem; 2000 May 04; 37 ( Pt 3)():360-6. PubMed ID: 10817252
    [Abstract] [Full Text] [Related]

  • 20. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).
    Dieplinger H, Kronenberg F.
    Wien Klin Wochenschr; 1999 Jan 15; 111(1):5-20. PubMed ID: 10067265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.